For Rs 628 crore JB Chemicals to buy brands from Sanzyme


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
With Rs 628 crore, the board of JB Chemicals will acquire a bunch of brands from Sanzyme Private Limited (SPL).

With Rs 628 crore, the board of JB Chemicals will acquire a bunch of brands from Sanzyme Private Limited (SPL). The brands in question are Sporlac, Oxalo, Lobun, Nano-Leo and Gynogen. 

Sporlac is India’s third-largest probiotics brand. Oxalo is a risk-free therapy that can decalcify kidney stones. Whereas, Lobun can delay the progression of chronic kidney diseases. The brands have a reach of 3 lakh chemists and 1 lakh prescribers. 

Nano Leo is a pro-sexual nutrient formulation for libido, erection, and orgasm in patients with erectile dysfunction. Gynogen stimulates the growth and recruitment of immature ovarian follicles in the ovary and is routinely used as a part of Assisted Reproductive Technology.

The turnover of these brands in FY20-21 was Rs 88 crores and for FY21-22 it was Rs 75 crores. The deal will mark JB Chemicals' entry into a range of sectors like probiotics, therapeutic nutraceuticals and reproductive health. 

The deal will close next month and is the first acquisition of JB Chemicals. JB Chemicals will scale up these brands pan-India. The brands will also gain immense visibility using JB Chemicals distribution network. 

They are a profitable business whose net profit in the quarter ended in September 2021 was Rs 97.88 crore. Citing IQVIA MAT December 2021 data, JBCPL said the revenue for the combined brands was Rs 160 crore.

Tags : #JBChemicals #Sanzyme #Sporlac #Oxalo #Lobun #Nano-Leo #Gynogen #funding #acquisition #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Medicolegal Risks in TelemedicineJune 24, 2025
Digital Mental Health Clinics in Tier-2 CitiesJune 24, 2025
AssisTech Foundation Hosts Inclusive Job Festival for Persons with DisabilitiesJune 23, 2025
Travel with Ease: Why Congestion Patches Are the Smart Traveler’s Secret WeaponJune 23, 2025
Paper-Tech Platform Paper Arizona Hits ₹100 Cr Annual Revenue Milestone, Eyes IPO Listing in 2026June 23, 2025
Eat Better to enhance its Quick Commerce Operations with UnicommerceJune 23, 2025
Stahl Unveils Blacksmith Signature Cast Iron Tawas: A Classic Essential with a Modern Update for Timeless Indian KitchensJune 23, 2025
Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trialsJune 23, 2025
Finding strength in struggle for gender equality and human rightsJune 23, 2025
CTS Speciality Hospital Brings Robotic Knee Surgery Ushering in a New Era of Joint CareJune 23, 2025
Air Quality & Cardiovascular Morbidity: The Missing LinkJune 23, 2025
Menstrual Product Tax Relief & Health AccessJune 23, 2025
Sports Medicine Goes Virtual via WearablesJune 23, 2025
The Silent Guardian: How Smart Pill Dispensers Bring Peace to Indian FamiliesJune 23, 2025
Low-Cost AI Diagnostics for Retinal DiseaseJune 23, 2025
Yoga Beyond Fitness: Olive Hospital Spreads Awareness on Its Preventive Health BenefitsJune 21, 2025
Medanta- The Medicity Underscores Commitment to Holistic Well-Being Through Large-Scale International Yoga Day CelebrationsJune 21, 2025
The Rise of Digital Symptom Checkers in IndiaJune 21, 2025
3-D Printed Prosthetics for Indian AmputeesJune 21, 2025
The Silent Drain: Why NAFLD is Hurting Middle Aged India's Health and WalletJune 21, 2025